Risk for Shoulder Conditions Small After Vaccination in Deltoid Muscle
Incidence of shoulder conditions per 10,000 vaccinations was 1.22 for adults (age 18 years or older) and 0.05 for children (age 3 to 17 years)
Miscellaneous Musculoskeletal Disorders
Evidence Weighed for Perioperative Use of bDMARDs
Limited evidence suggests that continuing biological DMARDs may lower risk for disease flares without increasing risk for postop complications
New Indication: Rinvoq for Psoriatic Arthritis
This slideshow shows drug information for Susvimo. Click here for the complete Susvimo monograph.
Study Supports Bimekizumab for Nonradiographic Axial Spondyloarthritis
The ongoing phase 3 BE MOBILE 1 study compared the efficacy and safety of bimekizumab to placebo in adults with active nr-axSpA.
New Drugs Approved in 2021
Visit our New Drug Products page to stay up-to-date on the latest drug approvals.
Gene Therapy Gets Fast Track Status for Pain Associated With Osteoarthritis of Knee
XT-150 is a locally injectable non-viral therapy expressing interleukin (IL)-10v, a proprietary modified variant of IL-10.
Significant Improvements Seen With Bimekizumab in Ankylosing Spondylitis Trial
The ongoing phase 3 BE MOBILE 2 study compared the efficacy and safety of bimekizumab to placebo in 332 adults with active ankylosing spondylitis.
Xeljanz/Xeljanz XR Approved for Active Ankylosing Spondylitis
The approval was based on data from a phase 3 study which evaluated tofacitinib in adults with active AS who had an inadequate response to at least 2 NSAIDs.
AHA: Oral Milvexian Promising for Prevention of VTE
In patients undergoing knee arthroplasty, postoperative incidence of venous thromboembolism lower with milvexian versus enoxaparin
Steroid Injection No Better for Long-Term Carpal Tunnel Symptoms
At five years, no difference seen in symptoms, but rates of subsequent surgical treatment lower with methylprednisolone versus saline injection
